APA (7th ed.) Citation

Bolijn, R., Spijkerman, A. M. W., Galenkamp, H., Blokstra, A., Coyer, L., Boyd, A., . . . Stronks, K. (2024). Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study. PLoS ONE, 19(10), 1. https://doi.org/10.1371/journal.pone.0311196

Chicago Style (17th ed.) Citation

Bolijn, Renee, Annemieke M. W. Spijkerman, Henrike Galenkamp, Anneke Blokstra, Liza Coyer, Anders Boyd, Maria Prins, and Karien Stronks. "Differences in SARS-CoV-2 Antibody Prevalence at the End of the Pre-vaccination Period Between Age Groups: A Cross-sectional Analysis of the Multi-ethnic Population-based HELIUS Study." PLoS ONE 19, no. 10 (2024): 1. https://doi.org/10.1371/journal.pone.0311196.

MLA (9th ed.) Citation

Bolijn, Renee, et al. "Differences in SARS-CoV-2 Antibody Prevalence at the End of the Pre-vaccination Period Between Age Groups: A Cross-sectional Analysis of the Multi-ethnic Population-based HELIUS Study." PLoS ONE, vol. 19, no. 10, 2024, p. 1, https://doi.org/10.1371/journal.pone.0311196.